Nupur Pharma Private Limited
About Nupur Pharma Private Limited
Data last updated:
Nupur Pharma Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 April 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2000PTC105495. Its GSTIN is 09AABCN0842K2ZE (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Manoj Goel Kumar and Nupur Goel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 19 Chitrakut Apartmenteast Arjun Nagar, Delhi, India – 110032.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.3 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹5.75 Lakh (net margin 1.1%) and EBITDA of ₹9.39 Lakh (EBITDA margin 1.8%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 38% over five years.
Court records list 6 cases involving the company, including 1 filed by the company and 5 filed against it; 6 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address19 Chitrakut Apartmenteast Arjun Nagar, Delhi, India – 110032
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Nupur Pharma Private Limited
The main business activity of Nupur Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Nupur Pharma Private Limited FY 2025 filings available
Nupur Pharma Private Limited reported revenue of ₹5.3 Cr (down 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Nupur Pharma Private Limited
Revenue fell 6% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 38%. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Nupur Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹9.39 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹5.75 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Nupur Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nupur Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Nupur Pharma Private Limited
Nupur Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| A R K Health Care Pvt Ltd | ₹5.32 Cr (FY 2024) | •••• | •••• | -34.0% | •••• | Manimajra, Chandigarh, India |
| Harihar Pharmaceuticals Private Limited | ₹5.32 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Bolangir, Odisha, India |
| Lexus India Limited | ₹5.32 Cr (FY 2024) | •••• | •••• | 99.0% | •••• | New Delhi, Delhi, India |
| Meticulous Pharmaceticals Private Limited | ₹5.31 Cr (FY 2025) | •••• | •••• | 36.0% | •••• | Uttar Pradesh, India |
| Swastik Formulations Private Limited | ₹5.3 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Uttar Pradesh, India |
| Nupur Pharma Private Limited this company | ₹5.3 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | Delhi, India |
| Edence Life Sciences Private Limited | ₹5.29 Cr (FY 2024) | •••• | •••• | 17.0% | •••• | Mumbai, Maharashtra, India |
| Synnova Intermediates Private Limited | ₹5.29 Cr (FY 2025) | •••• | •••• | 18325.0% | •••• | Mumbai, Maharashtra, India |
| Axolab Formulations Private Limited | ₹5.29 Cr (FY 2025) | •••• | •••• | 824.0% | •••• | Solan, Himachal Pradesh, India |
| SPR Oncocare Private Limited | ₹5.28 Cr (FY 2025) | •••• | •••• | 80.0% | •••• | Bangalore, Karnataka, India |
| Sure for Cure Farmulations (India ) Private Limited | ₹5.27 Cr (FY 2025) | •••• | •••• | -11.0% | •••• | Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Nupur Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Nupur Pharma Private Limited
Nupur Pharma Private Limited is audited by PRAVEEN KUMAR GOEL & ASSOCIATES for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| PRAVEEN KUMAR GOEL & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Nupur Pharma Private Limited
Nupur Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manoj Goel Kumar Also directs: Curecaps India Private Limited | Director | 28 Apr 2000 | 26 Years 5 Months | Current |
| Nupur Goel Also directs: Curecaps India Private Limited | Director | 12 Apr 2024 | 2 Years 5 Months | Current |
| Seema Goel Also directs: Curecaps India Private Limited | Director | 28 Dec 2006 | 19 Years 9 Months | Current |
Ownership and Shareholding of Nupur Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Nupur Pharma Private Limited
Nupur Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Nupur Pharma Private Limited
Nupur Pharma Private Limited has 6 court cases on record: 1 filed by Nupur Pharma, 5 filed against it. All cases are pending. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 5 | 6 |
Cases on record (3 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chandigarh | Cheque dishonour complaint | Filed against the company by Nectar Life Sciences Limited | Pending |
| District court, Chandigarh | Cheque dishonour complaint | Filed against the company by Nector Lifesciences Limited | Pending |
| District court, Ghaziabad, Uttar Pradesh | Criminal case | Filed by the company against Novatro Laboratries Pvt. Ltd | Pending |
Full case history
All 6 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Nupur Pharma Private Limited
Employment history and EPFO contributions of people linked to Nupur Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Nupur Pharma Private Limited
Nupur Pharma Private Limited has 4 board changes on record since 2000: 3 appointments and 1 cessation. The latest: Nupur Goel ceased to be Additional Director on 29 Sep 2024.
Credit Ratings, Litigation & Regulatory Alerts for Nupur Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Nupur Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nupur Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Nupur Pharma Private Limited
Nupur Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AABCN0842K2ZE | Uttar Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nupur Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nupur Pharma Private Limited
Nupur Pharma is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 April 2000 (26+ years old) and is registered under CIN U24239DL2000PTC105495.
Nupur Pharma reported revenue of ₹5.3 Cr for FY 2025 (down 6% YoY).
Nupur Pharma has 3 current directors:
- Manoj Goel Kumar - Director
- Nupur Goel - Director
- Seema Goel - Director
Nupur Pharma reported a net profit of ₹5.75 Lakh (net margin 1.1%) and EBITDA of ₹9.39 Lakh (EBITDA margin 1.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Nupur Pharma is -3% over three years and 38% over five years. In the latest year (FY 2025) revenue fell 6%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Nupur Pharma is 09AABCN0842K2ZE, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Nupur Pharma is U24239DL2000PTC105495. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nupur Pharma has 6 court cases on record: 1 filed by the company and 5 filed against it. 6 are pending.
Nupur Pharma was incorporated on 28 April 2000, making it 26+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Nupur Pharma by revenue are A R K Health Care Pvt Ltd, Harihar Pharmaceuticals Private Limited, Lexus India Limited, Meticulous Pharmaceticals Private Limited, Swastik Formulations Private Limited and 5 more, all in the Pharma industry (Formulations).
Nupur Goel ceased to be Additional Director on 29 Sep 2024. Nupur Goel was appointed as Director on 12 Apr 2024. Seema Goel was appointed as Director on 28 Dec 2006. Nupur Pharma has 4 board changes on record in total.